Reta – 24mg Vial
$540.00
Product Information
Reta belongs to our 3rd generation peptide line, developed to support advanced metabolic research. This 24mg vial delivers a high-dose option suitable for sustained or multi-phase experimental protocols, offering extended utility in in vitro applications.
As a triple-agonist peptide analog, Reta is of particular interest in studies involving multi-receptor signaling. It has been explored in research models examining appetite suppression, energy expenditure, glycemic control, and systemic regulation. Its unique activity profile across GLP-1, GIP, and glucagon pathways makes it a compelling compound in modern peptide science.
Key characteristics of Reta include:
-
Purity ≥ 99%
-
Lyophilized for maximum shelf stability
-
Precision-crafted for high dosing consistency
-
Suited for metabolic, endocrine, and cardiovascular-focused research
With its broad biological potential and high-quality formulation, Reta (24mg) supports researchers investigating comprehensive metabolic responses and next-generation peptide therapeutics.
Handling & Storage
Provided in lyophilized form for long-term storage. Store refrigerated after reconstitution. Do not freeze the reconstituted vial. Refer to lab-specific protocols for reconstitution and administration.
Note
For research use only. Not for human or veterinary use. Not intended for diagnostic or therapeutic purposes.
All items and product information provided on this website are intended strictly for informational and educational purposes only.
The products offered are designated exclusively for in vitro research use—meaning studies performed outside of a living organism, such as in a controlled laboratory setting.
These compounds are not drugs or medications and have not been approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition.
Any introduction of these products into the human or animal body is strictly prohibited by law.